Table 2

Distribution of the irbesartan and conventional treatment group according to change in albuminuria and SBP from baseline to month 6

Albuminuria response >median (reduction >18%)Total (%)Albuminuria response <median (reduction <18%)Total (%)Total (%)
Quartile 1 (<−50%)Quartile 2 (−50 to −18%)Quartile 3 (−18 to +34%)Quartile 4 (>+34%)
Irbesartan (N = 353)
 SBP response >median (reduction >11 mmHg)69 (19.5)56 (15.9)35.435 (9.9)33 (9.3)19.355
 SBP response <median (reduction <11 mmHg)40 (11.3)46 (13)24.445 (12.7)29 (8.2)21.045
 Total (%)6040
Conventional treatment (N = 178)
 SBP response >median (reduction >11 mmHg)7 (3.9)17 (9.6)13.521 (11.8)22 (12.4)24.238
 SBP response <median (reduction <11 mmHg)16 (9.0)14 (7.9)16.932 (18.0)49 (27.5)45.562
 Total (%)3070
  • Data are number of patients and (% of total).